The filing for resale of up to 5.3 million shares of Class A common stock by Ginkgo Bioworks Holdings could lead to a dilution of the value of existing shares. This is because the increase in the number of shares available in the market could potentially lower the price per share, assuming demand remains constant. Therefore, this news is likely to have a negative impact on the stock price in the short term.